Salute e Benessere
Sanofi Partners With Beano & Breakthrough T1D UK to Raise Awareness of autoimmune Type 1 Diabetes
T1D is an autoimmune, complex, and lifelong condition – and it can happen to anyone at any age even without family history. It can be a challenging disease with lifelong clinical, economic, and emotional unmet needs for patients and families. In the UK, there is a growing prevalence where approximately 400,000 people are living with the disease, including about 36,000 people 19 years of age and younger. It is known that T1D is not caused by diet or lifestyle, however, currently the causes of T1D are still not completely understood. Researchers are exploring the genes and environmental triggers to understand if they play a part in causing the body's immune system to malfunction and start attacking the insulin-producing beta cells in the pancreas. In the UK T1D is managed through insulin therapy and glucose monitoring.
General Manager, General Medicines UK and Ireland , Sanofi
Policy & Communications Director, Breakthrough T1D UK
Creative Director, Beano
World Diabetes Day, observed annually on November 14th , stands as a beacon of awareness for a global health challenge. This day transcends borders to shine a light on both Type 1 and Type 2 diabetes, emphasizing the importance of understanding their causes, symptoms, and treatments. More than just education, World Diabetes Day seeks to influence policy changes that improve diabetes care worldwide and offer vital support to those living with the condition. This day serves as a powerful reminder that everyone can play a part in addressing this global health issue.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and potentially life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Beano was first published in July 1938 and is still created every week in its original Dundee headquarters and printed in the UK. Beano recently reported an ABC of 46,295 and is in its fifth consecutive year of audience growth. The brand reaches over 5m fans a month across its digital and social channels. Beano Studios is a rebellious multi-media publishing, entertainment and creative business powered by data and insight. The Studio produces diverse content across TV and the award-winning Beano.com - as well as theatrical, live experiences, licensed products, the Beano Shop, and the legendary Beano comic and annual.
Diabetes UK. What causes Type 1 Diabetes? Available at:
https://www.diabetes.org.uk/diabetes-the-basics/types-of-diabetes/type-1/causes . [Accessed:
October 2024 ]
Sze M Ng and Astha Soni . (2023,
August 25 ). Ten-year review of trends in children with type 1 diabetes in
England and Wales . World Journal of Diabetes, 14(8), 1194–1201.
National Institute for Health and Care Excellence. "Type 1 Diabetes in Children and Young People: Incidence and Prevalence." , https://cks.nice.org.uk/topics/diabetes-type-1/background-information/incidence-prevalence/ . [Accessed: October 2024 ]
Mathew TK, Zubair M, Tadi P. Blood Glucose Monitoring. [Updated 2023 Apr 23]. In: StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2024 Jan.
View original content to download multimedia: https://www.prnewswire.co.uk/news-releases/sanofi-partners-with-beano--breakthrough-t1d-uk-to-raise-awareness-of-autoimmune-type-1-diabetes-302305430.html